HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ivana Cecic Selected Research

Dihematoporphyrin Ether (Porfimer Sodium)

10/2008Complement activation cascade and its regulation: relevance for the response of solid tumors to photodynamic therapy.
3/2008Acute phase response induction by cancer treatment with photodynamic therapy.
9/2007The impact of complement activation on tumor oxygenation during photodynamic therapy.
8/2006Acute phase response-associated systemic neutrophil mobilization in mice bearing tumors treated by photodynamic therapy.
3/2006Role of complement anaphylatoxin C3a in photodynamic therapy-elicited engagement of host neutrophils and other immune cells.
1/2006Deposition of complement proteins on cells treated by photodynamic therapy in vitro.
7/2005Characteristics of complement activation in mice bearing Lewis lung carcinomas treated by photodynamic therapy.
2/2005Photodynamic therapy-induced cell surface expression and release of heat shock proteins: relevance for tumor response.
9/2002Mediators of peripheral blood neutrophilia induced by photodynamic therapy of solid tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ivana Cecic Research Topics

Disease

11Neoplasms (Cancer)
10/2008 - 09/2002
3Fibrosarcoma
03/2008 - 03/2006
3Acute-Phase Reaction
03/2008 - 03/2006
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2008 - 09/2002
2Carcinoma (Carcinomatosis)
09/2007 - 07/2005
1Inflammation (Inflammations)
03/2008
1Hypoxia (Hypoxemia)
07/2007
1Wounds and Injuries (Trauma)
08/2006
1Hemolysis
08/2006

Drug/Important Bio-Agent (IBA)

111-phenyl-3,3-dimethyltriazene (PDT)IBA
10/2008 - 09/2002
9Dihematoporphyrin Ether (Porfimer Sodium)FDA Link
10/2008 - 09/2002
6Complement System Proteins (Complement)IBA
10/2008 - 08/2004
3Proteins (Proteins, Gene)FDA Link
10/2008 - 08/2006
2Photosensitizing Agents (Photosensitizers)IBA
10/2008 - 09/2007
2Acute-Phase Proteins (Acute-Phase Protein)IBA
03/2008 - 08/2006
2Oxygen (Dioxygen)IBA
09/2007 - 07/2007
2Complement C3 (C3 Complement)IBA
09/2007 - 08/2006
1CD59 AntigensIBA
10/2008
1CD55 Antigens (Decay Accelerating Factor)IBA
10/2008
1Complement Factor H (Factor H)IBA
10/2008
1ProperdinIBA
10/2008
1Serum Amyloid P-ComponentIBA
03/2008
1GlucocorticoidsIBA
03/2008
1Mannose-Binding Lectin (Mannan-Binding Lectin)IBA
03/2008
1Interleukin-6 (Interleukin 6)IBA
03/2008
1C-Reactive ProteinIBA
03/2008
1Hormones (Hormone)IBA
03/2008
1vadimezanIBA
07/2007
1beta-Galactosidase (Lactaid)IBA
07/2007
1Renilla LuciferasesIBA
07/2007
1Thymidine KinaseIBA
07/2007
1Red Fluorescent ProteinIBA
07/2007
1ElementsIBA
01/2006
1HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA
02/2005
1Heat-Shock Proteins (Heat-Shock Protein)IBA
02/2005
1StreptokinaseFDA Link
08/2004
1ZymosanIBA
08/2004
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
08/2004

Therapy/Procedure

10Photochemotherapy (Photodynamic Therapy)
10/2008 - 09/2002
2Therapeutics
07/2005 - 08/2004